Literature DB >> 25815143

N (1)-Fluoroalkyltryptophan Analogues: Synthesis and in vitro Study as Potential Substrates for Indoleamine 2,3-Dioxygenase.

Jean Henrottin1, Astrid Zervosen2, Christian Lemaire2, Frédéric Sapunaric2, Sophie Laurent2, Benoit Van den Eynde3, Serge Goldman4, Alain Plenevaux2, André Luxen2.   

Abstract

Indoleamine 2,3-dioxygenase (hIDO) is an enzyme that catalyzes the oxidative cleavage of the indole ring of l-tryptophan through the kynurenine pathway, thereby exerting immunosuppressive properties in inflammatory and tumoral tissues. The syntheses of 1-(2-fluoroethyl)-tryptophan (1-FETrp) and 1-((1-(2-fluoroethyl)-1H-1,2,3-triazol-4-yl)methyl)-tryptophan, two N (1)-fluoroalkylated tryptophan derivatives, are described here. In vitro enzymatic assays with these two new potential substrates of hIDO show that 1-FETrp is a good and specific substrate of hIDO. Therefore, its radioactive isotopomer, 1-[(18)F]FETrp, should be a molecule of choice to visualize tumoral and inflammatory tissues and/or to validate new potential inhibitors.

Entities:  

Keywords:  1-(2-fluoroethyl)-tryptophan; Tryptophan; indoleamine 2,3-dioxygenase; kynurenine; positron emission tomography; tryptophan 2,3-dioxygenase

Year:  2015        PMID: 25815143      PMCID: PMC4360160          DOI: 10.1021/ml500385d

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  36 in total

1.  Brain kinetics of 11 C-labelled L-tryptophan and 5-hydroxy-L-tryptophan in the rhesus monkey. A study using positron emission tomography.

Authors:  P Hartvig; K J Lindner; J Tedroff; Y Andersson; P Bjurling; B Långström
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Evidence for a ferryl intermediate in a heme-based dioxygenase.

Authors:  Ariel Lewis-Ballester; Dipanwita Batabyal; Tsuyoshi Egawa; Changyuan Lu; Yu Lin; Marcelo A Marti; Luciana Capece; Dario A Estrin; Syun-Ru Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-29       Impact factor: 11.205

3.  Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies.

Authors:  Csaba Juhász; Zeina Nahleh; Ian Zitron; Diane C Chugani; Majid Z Janabi; Sudeshna Bandyopadhyay; Rouba Ali-Fehmi; Thomas J Mangner; Pulak K Chakraborty; Sandeep Mittal; Otto Muzik
Journal:  Nucl Med Biol       Date:  2012-03-22       Impact factor: 2.408

Review 4.  Kynurenines in the CNS: recent advances and new questions.

Authors:  László Vécsei; Levente Szalárdy; Ferenc Fülöp; József Toldi
Journal:  Nat Rev Drug Discov       Date:  2012-12-14       Impact factor: 84.694

Review 5.  Indoleamine 2,3-dioxygenase in immune suppression and cancer.

Authors:  Alexander J Muller; George C Prendergast
Journal:  Curr Cancer Drug Targets       Date:  2007-02       Impact factor: 3.428

6.  Reassessment of the reaction mechanism in the heme dioxygenases.

Authors:  Nishma Chauhan; Sarah J Thackray; Sara A Rafice; Graham Eaton; Michael Lee; Igor Efimov; Jaswir Basran; Paul R Jenkins; Christopher G Mowat; Stephen K Chapman; Emma Lloyd Raven
Journal:  J Am Chem Soc       Date:  2009-04-01       Impact factor: 15.419

7.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

8.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Authors:  Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

9.  Inhibitory substrate binding site of human indoleamine 2,3-dioxygenase.

Authors:  Changyuan Lu; Yu Lin; Syun-Ru Yeh
Journal:  J Am Chem Soc       Date:  2009-09-16       Impact factor: 15.419

10.  IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival.

Authors:  Derek A Wainwright; Irina V Balyasnikova; Alan L Chang; Atique U Ahmed; Kyung-Sub Moon; Brenda Auffinger; Alex L Tobias; Yu Han; Maciej S Lesniak
Journal:  Clin Cancer Res       Date:  2012-08-29       Impact factor: 12.531

View more
  9 in total

1.  Synthesis and evaluation of an AZD2461 [18F]PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant.

Authors:  Sean W Reilly; Laura N Puentes; Alexander Schmitz; Chia-Ju Hsieh; Chi-Chang Weng; Catherine Hou; Shihong Li; Yin-Ming Kuo; Prashanth Padakanti; Hsiaoju Lee; Aladdin A Riad; Mehran Makvandi; Robert H Mach
Journal:  Bioorg Chem       Date:  2018-10-17       Impact factor: 5.275

Review 2.  Utility of MRI, PET, and ictal SPECT in presurgical evaluation of non-lesional pediatric epilepsy.

Authors:  Csaba Juhász; Flóra John
Journal:  Seizure       Date:  2019-05-11       Impact factor: 3.184

3.  Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer.

Authors:  Yangchun Xin; Xiaofei Gao; Li Liu; Woo-Ping Ge; Manoj K Jain; Hancheng Cai
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

4.  Improved Radiosynthesis and Biological Evaluations of L- and D-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of IDO-Mediated Kynurenine Pathway of Tryptophan Metabolism.

Authors:  Yangchun Xin; Hancheng Cai
Journal:  Mol Imaging Biol       Date:  2017-08       Impact factor: 3.488

5.  Fluorine-18-Labeled PET Radiotracers for Imaging Tryptophan Uptake and Metabolism: a Systematic Review.

Authors:  Flóra John; Otto Muzik; Sandeep Mittal; Csaba Juhász
Journal:  Mol Imaging Biol       Date:  2020-08       Impact factor: 3.488

6.  Assessment of Tryptophan Uptake and Kinetics Using 1-(2-18F-Fluoroethyl)-l-Tryptophan and α-11C-Methyl-l-Tryptophan PET Imaging in Mice Implanted with Patient-Derived Brain Tumor Xenografts.

Authors:  Sharon K Michelhaugh; Otto Muzik; Anthony R Guastella; Neil V Klinger; Lisa A Polin; Hancheng Cai; Yangchun Xin; Thomas J Mangner; Shaohui Zhang; Csaba Juhász; Sandeep Mittal
Journal:  J Nucl Med       Date:  2016-10-20       Impact factor: 10.057

7.  Imaging cerebral tryptophan metabolism in brain tumor-associated depression.

Authors:  Edit Bosnyák; David O Kamson; Michael E Behen; Geoffrey R Barger; Sandeep Mittal; Csaba Juhász
Journal:  EJNMMI Res       Date:  2015-10-17       Impact factor: 3.138

Review 8.  The therapeutic potential of targeting tryptophan catabolism in cancer.

Authors:  Luis F Somarribas Patterson; Soumya R Mohapatra; Dyah L Dewi; Christiane A Opitz; Ahmed Sadik; Michael Platten; Saskia Trump
Journal:  Br J Cancer       Date:  2019-12-10       Impact factor: 7.640

Review 9.  Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry.

Authors:  Alice Coletti; Francesco Antonio Greco; Daniela Dolciami; Emidio Camaioni; Roccaldo Sardella; Maria Teresa Pallotta; Claudia Volpi; Ciriana Orabona; Ursula Grohmann; Antonio Macchiarulo
Journal:  Medchemcomm       Date:  2017-05-16       Impact factor: 3.597

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.